PMID- 21351537 OWN - NLM STAT- MEDLINE DCOM- 20111115 LR - 20181201 IS - 1009-3591 (Print) IS - 1009-3591 (Linking) VI - 17 IP - 1 DP - 2011 Jan TI - [Effects of jiawei huzhang san decoction on the expressions of inflammatory factors MCP-1 and PDGF-BB in rat models of experimental autoimmune prostatitis]. PG - 83-8 AB - OBJECTIVE: To study the effects of Jiawei Huzhang San (JWHZS) decoction on the expressions of the inflammatory factors monocyte chemoattractant protein-1 (MCP-1) and platelet-derived growth factor-BB (PDGF-BB) on experimental autoimmune prostatitis in rats. METHODS: Twelve male Wistar rats were taken as normal controls, and models of experimental autoimmune prostatitis were established in another 60 by injection of SC purified prostate protein with FCA, and then divided into five groups to be treated with normal saline, indomethacin, high-dose JWHZS (0.445 g/kg), medium-dose JWHZS (0.223 g/kg) and low-dose JWHZS (0.089 g/kg), respectively. All the rats were sacrificed at 30 days after the treatment for detection of the mRNA and protein expressions of inflammatory factors by immunohistochemistry and fluorescent quantitative RT-PCR. RESULTS: In the high-, medium- and low-dose JWHZS groups, the mRNA expressions of MCP-1 (0.31 +/- 0.14, 0.49 +/- 0.21 and 0.62 +/- 0.28) and PDGF-BB (0.50 +/- 0.22, 0.54 +/- 0.17 and 0.71 +/- 0.29), and the protein expressions of MCP-1 (677 +/- 208, 725 +/- 311 and 1302 +/- 884) and PDGF-BB (1265 +/- 698, 1347 +/- 827 and 1655 +/- 812) were significantly lower than in the model control group (MCP-1 mRNA: 1.12 +/- 0.43; MCP-1 protein: 2201 +/- 934; PDGF-BB mRNA: 1.14 +/- 0.51; PDGF-BB protein: 2754 +/- 852) (P < 0.05). And JWHZS exhibited a significantly better activity at high and medium doses than at a low dose (P < 0.05). In the indomethacin control group, both the mRNA and protein expressions of MCP-1 (0.71 +/- 0.34 and 1824 +/- 1157) and PDGF-BB (1.08 +/- 0.37 and 2493 +/- 924) were markedly higher than in the JWHZS groups (P < 0.01). CONCLUSION: Down-regulation of the inflammatory factors MCP-1 and PDGF-BB may be the important molecular mechanism of JWHZS acting on experimental autoimmune prostatitis. FAU - Zhou, Qing AU - Zhou Q AD - Department of Surgery, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410007, China. supergoon@163.com FAU - Tian, Xue-fei AU - Tian XF FAU - Gong, Xiu-ying AU - Gong XY FAU - Feng, Ya-lan AU - Feng YL FAU - Hu, Hua AU - Hu H LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Nan Ke Xue JT - Zhonghua nan ke xue = National journal of andrology JID - 101093592 RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (Proto-Oncogene Proteins c-sis) RN - 0 (RNA, Messenger) RN - 1B56C968OA (Becaplermin) SB - IM MH - Animals MH - Autoimmune Diseases/*drug therapy/metabolism MH - Becaplermin MH - Chemokine CCL2/*metabolism MH - Disease Models, Animal MH - Drugs, Chinese Herbal/*therapeutic use MH - Inflammation MH - Male MH - *Phytotherapy MH - Platelet-Derived Growth Factor/*metabolism MH - Prostatitis/*drug therapy/metabolism MH - Proto-Oncogene Proteins c-sis MH - RNA, Messenger/genetics MH - Rats MH - Rats, Wistar EDAT- 2011/03/01 06:00 MHDA- 2011/11/16 06:00 CRDT- 2011/03/01 06:00 PHST- 2011/03/01 06:00 [entrez] PHST- 2011/03/01 06:00 [pubmed] PHST- 2011/11/16 06:00 [medline] PST - ppublish SO - Zhonghua Nan Ke Xue. 2011 Jan;17(1):83-8.